TG Therapeutics TGTX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $461.9M+3.3% | $447.18M-0.1% | $447.47M+640% | $60.46M+54.4% | $39.15M+67.4% | ||
| $83K+40.7% | $59K+25.5% | $47K+14.6% | $41K-12.8% | $47K-30.9% | ||
| $69.65M+7.7% | $64.67M+6.1% | $60.97M+10.7% | $55.05M+14.3% | $48.17M+13.2% | ||
| —— | —— | —— | —— | —— | ||
| $240K+12.1% | $214K+27.4% | $168K+50.0% | $112K+60.0% | $70K+55.6% | ||
| —— | —— | —— | —— | —— | ||
| $185.11M+103% | $91.24M-6.8% | $97.85M+350% | $21.76M+46.2% | $14.88M+69.9% | ||
| —— | —— | —— | —— | —— | ||
| $306.14M+437% | -$90.79M0.0% | -$90.79M-174% | $121.91M-5.1% | $128.49M-4.5% | ||
| $305.04M+388% | -$105.78M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TG Therapeutics generate?
- TG Therapeutics (TGTX) generated -$95.4M in operating cash flow over the trailing twelve months.
- What is TG Therapeutics's free cash flow?
- After $240.0K of capital expenditures, TG Therapeutics's free cash flow was -$95.6M over the trailing twelve months, down 66.2% year over year.
- Where does TG Therapeutics's cash flow data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
